GET DAILY SIGNALSISRG vs UPS: Weighing Robotic Surgery Growth Against Logistics Turnaround Momentum
Key Takeaways
- Intuitive Surgical (ISRG) delivered 22% revenue growth in its latest quarter, but shares fell sharply on a $450 million antitrust settlement, slower U.S. procedure growth, and planned instrument price cuts.
- United Parcel Service (UPS) beat estimates and raised full-year guidance, with shares climbing roughly 9% following its report as margin-focused strategy gains traction.
- The two companies occupy very different risk profiles: ISRG is a high-multiple growth story facing valuation and legal headwinds, while UPS is a value-oriented turnaround with a dividend yield near 6%.
- Relative momentum currently favors UPS, whose improving earnings revisions and revenue quality contrast with ISRG's contracting margins and negative price reaction to solid results.
- Tickeron AI Verdict: UPS is the favored ticker in this comparison, reflecting stronger trend consistency and improving fundamental momentum relative to ISRG.
- For deeper context on each name, explore ISRG Major News and ISRG Today's Price Move, as well as UPS Major News and UPS Today's Price Move.
- To see how AI-powered strategies are navigating current market conditions, visit Trending AI Robots.
Setting the Stage
Intuitive Surgical (ISRG) and United Parcel Service (UPS) rarely sit side by side on an investor's watchlist, yet they offer a revealing study in contrasting market positioning. One is a fast-growing medical technology leader that sells robotic surgical systems; the other is a global logistics giant navigating a deliberate shift toward higher-margin shipments. This stock comparison matters for traders weighing growth at a premium against value with a turnaround catalyst, and for investors evaluating how relative performance, sentiment, and sector exposure shape near-term risk and reward across two very different business models. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Intuitive Surgical's Recent Results
Intuitive Surgical is the dominant force in robotic-assisted surgery through its da Vinci and Ion platforms. In its most recent quarter, revenue rose 22% year over year to $3.05 billion, while adjusted earnings per share (EPS) reached $3.00, exceeding analyst expectations. Worldwide procedures grew about 15%, and system placements climbed 28%, with the newer da Vinci 5 accounting for a large share of installations.
Despite these strong operating results, the stock has struggled in recent weeks. A $450 million pretax charge tied to an antitrust class-action settlement cut GAAP net income, while management disclosed that new pricing actions will reduce instrument and accessory revenue per procedure by roughly 3% to 5% once fully implemented. Slower U.S. procedure growth, which decelerated to around 10%, further pressured sentiment. Over the past year, shares have meaningfully underperformed the broader market, reflecting valuation concerns, rising competition from rivals such as Medtronic and Johnson & Johnson, and margin compression from higher research and development spending.
United Parcel Service's Recent Results
United Parcel Service is one of the world's largest package delivery and logistics companies, with its U.S. domestic segment contributing roughly two-thirds of total revenue. In its latest quarter, consolidated revenue rose 6.7% to $22.9 billion, and adjusted EPS of $1.69 beat expectations. The company also raised its full-year revenue, operating profit, EPS, and free cash flow guidance, a signal management sees in strengthening fundamentals.
The stock has responded favorably in recent weeks, gaining about 9% following the report. The driver is a deliberate strategic shift: UPS has completed a reduction in lower-margin Amazon volume and is now earning more per package, with revenue per piece rising faster than cost per piece. This focus on "revenue quality" lifted U.S. domestic operating profit by more than 14%, even as overall volume declined. International operations returned to operating profit growth, and healthcare logistics and data-center services are emerging as growth areas. The company's roughly 6% dividend yield and improving cash flow coverage add appeal for income-focused investors, though volume declines and a still-recovering margin profile remain key risks. From what I see, this margin discipline stands out as a key differentiator right now.
Head-to-Head Comparison
The clearest contrast between ISRG and UPS lies in their growth-versus-value positioning. ISRG is a premium-priced healthcare innovator whose razor-and-blade model depends on recurring instrument revenue and procedure volume growth. UPS is a capital-intensive industrial whose turnaround hinges on disciplined cost cutting and pricing power rather than unit growth.
Growth drivers also differ. ISRG's upside rests on international expansion, adoption of newer systems, and broader benign-procedure penetration, while UPS is betting on premium shipments, healthcare logistics, and network automation to expand margins. On the risk side, ISRG faces litigation exposure, reimbursement uncertainty, and rising competition; UPS contends with falling volume, e-commerce giants building their own delivery networks, and execution risk in its restructuring.
Sentiment has diverged sharply. ISRG's solid earnings were met with selling pressure, suggesting elevated expectations are already priced in. UPS's results triggered a rally, as improving margin trends and raised guidance surprised to the upside. This relative momentum, combined with UPS's more attractive valuation and income support, gives it a near-term positioning edge, even though ISRG retains a stronger long-term structural growth profile.
Tickeron AI Verdict
Based on observable factors such as trend consistency, relative performance, earnings revision momentum, and catalyst clarity, Tickeron's AI would likely favor UPS in the current environment. The stock's improving revenue quality, expanding margins, and positive post-earnings momentum suggest a more stable and favorable near-term trend than ISRG, which faces margin compression, legal charges, and a negative market reaction to otherwise strong results. This assessment is probabilistic rather than definitive: ISRG's long-term growth runway remains compelling, but UPS currently offers more favorable momentum and risk-adjusted positioning. As always, conditions can shift, and both names warrant ongoing monitoring. I’m watching this closely as earnings trends evolve.
Exploring AI Tools in Practice
In my research process, I frequently rely on Tickeron’s AI Trading Bots to evaluate how different automated strategies perform across varying market conditions. These tools allow me to test approaches that align with specific risk levels and timeframes, providing additional perspective when comparing names like these two. It helps refine my view on relative momentum without replacing core fundamental analysis.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
ISRG sees MACD Histogram just turned negative
ISRG saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 10, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 43 instances where the indicator turned negative. In 29 of the 43 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 67%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for ISRG moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 17 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 45%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ISRG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.
ISRG broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Momentum Indicator moved above the 0 level on November 13, 2026. You may want to consider a long position or call options on ISRG as a result. In 52 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
Following a +10.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where ISRG advanced for three days, in 211 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
The Aroon Indicator entered an Uptrend today. In 179 of 265 cases where ISRG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. ISRG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 51 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 72 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ISRG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.805) is normal, around the industry mean (4.964). P/E Ratio (51.222) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (1.931) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (12.469) is also within normal values, averaging (56.876).
The Tickeron PE Growth Rating for this company is 80 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of robotic technologies used for surgeries
Industry PharmaceuticalsOther
Advertisement